HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Hillhouse Capital Related

449.926

-3.560-0.78%

Number of Gainers:8

Number of Losers:39

Number of Flat:4

PE:- -

High:453.507

Open:453.447

Low:445.681

Close:453.486

Volume:245.15M

Turnover:5.43B

Market Cap:2.84T

Float Cap:1.98T

Loading ...

China Res Mixc (01209) Climbs Over 4% In Afternoon Trade As Mall Retail Sales Surge Amid Sector Headwinds

HK Stock Alert: Keymed Bio Surges Over 3% on Landmark Licensing Deal with Aeira

Meituan's Food-Delivery Profitability Could Remain Resilient Despite Seasonal Pressure

Keymed Biosciences Climbs on Licensing Deal with Aeira Pte

Keymed Biosciences Signs Licensing Deal for Kangyueda in 18 Markets

Final Countdown: Gansu's 16th Provincial Games Kick Off in Just 24 Hours

We Might See A Profit From Venus Medtech (Hangzhou) Inc. (HKG:2500) Soon

Simply Wall St.

Asian Growth Companies With High Insider Ownership September 2026

Simply Wall St.

Brazil Antitrust Body Orders Deeper Delivery Review After Keeta Setback

HBM Holdings Clarifies Reasons Behind Executive Director's Departure

Xtep International Holdings (SEHK:1368) Reported Softer Half Year Results, Is The Stock Cheap?

Simply Wall St.

Keymed Biosciences Licenses Stapokibart Marketing, Sales Rights in 18 Southeast and Central Asia Markets to Aeira

KeyMed Biosciences - Aeira Responsible for Registration and Commercialization of Stapokibart Injection in 18 Countries and Regions

THOMSON REUTERS

KeyMed Biosciences - Enters Exclusive Licensing Agreement with Aeira Pte for Stapokibart Injection

THOMSON REUTERS

Simcere Pharma repurchases 1.053 million shares for around HK$12.36 million on September 2

Simcere Pharma Files HKEX Next-Day Disclosure Return on Share Repurchase for Cancellation

REMEGEN Discloses Cumulative Buyback of 41,000 A-Shares by End of August

MicroPort FireShield Coronary Covered Stent Enters China NMPA Innovative Device Review Channel

Executive Director Wang Yuxiao Reduces Stake in Remegen (09995) by 13,500 Shares at Approximately HK$81.54 Each

Shenzhen Regulator Launches 2026 Roadshow Selection for Key Medical Device Innovation Projects

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnest.com/stock/BK1583/news?page=11"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK1583","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1583\",,,,,undefined,":{"symbol":"BK1583","market":"HK","secType":"PLATE","nameCN":"Hillhouse Capital Related","latestPrice":449.92596,"timestamp":1789104939059,"preClose":453.48572,"halted":0,"volume":245149077,"delay":0,"changeRate":-0.00785,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Trading","change":-3.559753,"latestTime":"09-11 13:35:39","open":453.44696,"high":453.50705,"low":445.6806,"amount":5426193878,"amplitude":0.017258,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1789114200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1789090200000,1789099200000],[1789102800000,1789113600000]],"pbRate":2.061246,"peRate":43.541097,"turnoverRate":0.002363,"increases":8,"decrements":39,"flats":2,"marketCap":2844196302784,"floatMarketCap":1977923572672},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1583\",,,,,undefined,":{"symbol":"BK1583","high":453.50705,"amplitude":0.017258,"preClose":453.48572,"low":445.6806,"pbRate":"2.061246","latestPrice":449.92596,"volume":245149077,"delay":0,"open":453.44696,"prevYearClose":503.90085,"prevWeekClose":481.394,"prevMonthClose":473.951,"prevQuarterClose":402.118,"fiveDayClose":481.394,"twentyDayClose":480.55,"sixtyDayClose":406.275,"secType":"PLATE","market":"HK","turnoverRate":0.002363,"peRate":43.541097,"marketCap":2844196302784,"floatMarketCap":1977923572672,"timestamp":1789104939059,"nameCN":"Hillhouse Capital Related"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1583\",,,,undefined,":{"bkCode":"BK1583","up":8,"down":39,"flat":4},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1583\",pageSize:20,pageCount:11,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1172975704","title":"China Res Mixc (01209) Climbs Over 4% In Afternoon Trade As Mall Retail Sales Surge Amid Sector Headwinds","url":"https://stock-news.laohu8.com/highlight/detail?id=1172975704","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1172975704?lang=en_us&edition=fundamental","pubTime":"2026-09-03 14:48","pubTimestamp":1788418096,"startTime":"0","endTime":"0","summary":"Shares of CHINA RES MIXC (01209) advanced more than 4% in the afternoon session on Monday. As of the time of writing, the stock was trading 3.74% higher at HK$40.50, with turnover reaching HK$261...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0082770016.USD","01209","BK4588","LU0456827905.SGD","LU0456846285.SGD","LU0620787316.HKD","LU0051755006.USD","BK1258","LU0082770016.SGD","BK1229","VXUS","KCAI","LU0164939612.USD","BK1542","JPRE","BK1583","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128255768","title":"HK Stock Alert: Keymed Bio Surges Over 3% on Landmark Licensing Deal with Aeira","url":"https://stock-news.laohu8.com/highlight/detail?id=1128255768","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128255768?lang=en_us&edition=fundamental","pubTime":"2026-09-03 14:18","pubTimestamp":1788416295,"startTime":"0","endTime":"0","summary":"Shares of KEYMED BIO-B (02162) climbed more than 3% in Hong Kong trading, last up 2.83% at HK$79.95 with turnover reaching HK$70.71 million. The rally follows the company's announcement of an...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","02162","BK1161","BK4588","KCAI","BK1583","BK1587","VXUS","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664216998","title":"Meituan's Food-Delivery Profitability Could Remain Resilient Despite Seasonal Pressure","url":"https://stock-news.laohu8.com/highlight/detail?id=2664216998","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664216998?lang=en_us&edition=fundamental","pubTime":"2026-09-03 14:15","pubTimestamp":1788416100,"startTime":"0","endTime":"0","summary":"0615 GMT - Profitability for Meituan's food-delivery segment could remain resilient despite near-term seasonal pressure, says UOB Kay Hian's Julia Pan in a note. The Chinese food-delivery platform expects the segment's profitability to weaken in 3Q from 2Q, but to stay sufficient to cover any losses from the instant-shopping division, she says. Pressure on the company's food-delivery unit economics likely reflects summer-season competition and strategic investment, the analyst says. Meanwhile, in-store, hotel and travel segment margins are likely to normalize in 3Q amid softer travel demand and higher marketing expenses, she adds. UOB Kay Hian maintains its hold rating and 76.00 Hong Kong dollar target price. Shares decline 0.7% to HK$78.20.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0261950983.USD","LU1770034418.SGD","LU0431992006.USD","LU1008478684.HKD","LU1064130708.USD","LU0173614495.USD","LU1048588211.SGD","LU0821914370.USD","LU2087589342.USD","BK1591","SG9999000459.SGD","LU0708995583.HKD","LU0210526637.USD","BK1575","LU0084288322.USD","LU0251144936.SGD","LU0588545490.SGD","LU0320764755.SGD","LU1224709979.USD","LU1188198961.HKD","LU0214875030.USD","LU0456827905.SGD","SG9999001903.USD","IE00B5MMRT66.SGD","LU0132412106.USD","LU0918141705.HKD","LU2242644610.SGD","LU0572944931.SGD","LU0878005551.USD","LU0819123356.HKD","LU0823426480.USD","LU2125910500.SGD","LU0326950275.SGD","LU2488822045.USD","LU0314109678.HKD","LU0345776255.USD","LU0577902371.SGD","IE0008369823.USD","LU0588545904.SGD","LU1226287529.USD","LU1868837722.USD","BK1604","LU0315178854.USD","SG9999014674.SGD","IE0008368742.USD","LU0348788117.USD","LU0164880469.USD","IE00BPRC5H50.USD","LU0051755006.USD","LU0054450605.USD","LU0048597586.USD","LU1688375341.USD","03690","LU2097828631.EUR","LU0594300419.USD","LU0196878994.USD","LU0828237510.HKD","LU1880383366.USD","LU0359202008.SGD","LU2097828474.EUR","LU0348825331.USD","LU0589944569.HKD","LU2152927971.USD","LU0499858602.USD","LU0370786039.SGD","LU0633140560.USD","LU0164865239.USD","LU0231483743.USD","LU1105468828.SGD","LU0828238088.HKD","LU0054237671.USD","LU0823038988.USD","LU1675838814.USD","LU0244354667.USD","LU0417516902.SGD","LU1960683339.HKD","LU0072913022.USD","SG9999002463.SGD","LU0348816934.USD","LU0650527681.SGD","LU1282648689.USD","LU2045819591.USD","LU0052750758.USD","IE00B3M56506.USD","LU2476274720.SGD","LU1303224171.USD","BK1615","LU0737861699.HKD","SG9999000327.SGD","LU1807302812.USD","LU0143863198.USD","LU2226246903.HKD","SG9999001689.USD","MPNGY","LU0456846285.SGD","LU2097828805.USD","HMTD.SI","LU0348805143.USD","LU1152091754.HKD","LU0880133367.SGD","LU0531971595.HKD","IE0032431581.USD","LU0502904849.HKD","LU0047713382.USD","LU0449509016.USD","LU2039709279.SGD","LU1831875114.USD","BK1233","LU0979878070.USD","LU1152091168.USD","LU0140636845.USD","LU1720050803.USD","LU1868838027.USD","LU1993786604.SGD","LU0287142896.SGD","IE00B543WZ88.USD","LU0327786744.USD","LU0588545730.USD","KWEB","LU0326948709.USD","LU0593848301.USD","LU1328615791.USD","SG9999002562.SGD","LU0873338254.USD","LU0605514214.HKD","LU1323998911.USD","IE00B0JY6N72.USD","LU0499858438.USD","LU0672654166.SGD","LU2148510915.USD","LU2399975544.HKD","LU0011963245.USD","LU0455707207.USD","LU0211977185.USD","LU0320764599.SGD","LU0797268264.HKD","LU0823040885.USD","LU0067412154.USD","LU1813983027.USD","LU0577902538.SGD","LU2097828557.USD","LU0633140727.USD","LU0823039010.USD","LU1481107354.HKD","METmain","LU0823041008.USD","BK1521","LU1023057109.AUD","LU1808992512.USD","LU1328277881.USD","IE00B031HY20.USD","LU0039217434.USD","LU0269904917.USD","LU0871576103.HKD","LU0683595622.HKD","LU0543330483.HKD","LU0577902298.EUR","LU0117841782.USD","LU0417516738.SGD","LU0449515922.USD","LU0143863784.USD","LU0345775950.USD","LU1102505929.USD","SG9999002828.SGD","IE00B29SXG58.USD","LU2097828714.EUR","LU2778985437.USD","BK1583","LU1719994722.HKD","LU1868837565.USD","LU1064131003.USD","LU0588546209.SGD","LU0868486357.SGD","LU0128522157.USD","LU0918141887.USD","LU0348827113.USD","LU1242518857.USD","LU1251922891.USD","LU0540923850.HKD","LU1734074674.USD","LU0541502299.USD","LU0501845795.SGD","LU0181495838.USD","BK1142","LU0165289439.USD","LU0359201612.USD","LU1048596156.SGD","BK1589","LU0348814723.USD","LU0561508036.HKD","LU0043850808.USD","LU0577902611.USD","LU0823426308.USD","LU0106252389.USD","LU0029875118.USD","LU1242518931.SGD","LU0594300179.USD","LU0049853897.USD","LU0307460666.USD","LU2257852520.SGD","LU0228659784.USD","LU0611395673.USD","LU0856984785.SGD","LU1794554557.SGD","LU1102505762.USD","IE0034224299.USD","LU0634319403.HKD","LU0865486749.SGD","LU0828237940.HKD","LU0164872284.USD","LU0463099449.HKD","BK1618","LU0541501648.USD","LU0348735423.USD","LU1961090484.USD","LU0509642566.USD","LU0149721374.USD","LU0700851271.USD","LU0819121731.USD","LU0359201885.HKD","LU1880383440.USD","BK1610","LU0048580855.USD","LU0577902454.USD","LU2476274308.USD","IE00BF5LJ272.USD","LU1770036033.HKD","LU0072462343.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664826668","title":"Keymed Biosciences Climbs on Licensing Deal with Aeira Pte","url":"https://stock-news.laohu8.com/highlight/detail?id=2664826668","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664826668?lang=en_us&edition=fundamental","pubTime":"2026-09-03 12:31","pubTimestamp":1788409914,"startTime":"0","endTime":"0","summary":"BUZZ-Keymed Biosciences climbs on licensing deal with Aeira Pte** Shares of Keymed Biosciences Inc2162.HKclimb 2.9% in the third straight rising session to HK$80, their highest level since August 27** Keymed says it entered into an exclusive licensing agreement with pharmaceutical firm Aeira Pte, on marketing registration and commercialization of Stapokibart injection - an antibody drug for treatment of topic dermatitis, in 18 countries and regions including Southeast and Central Asia** Keymed says it will receive an upfront payment, milestone payments and commercialization milestone payments and it is entitled to receive royalties of up to a high double-digit percentage based on product net sales in the licensed territory** YTD, stock up 46.7%, Hang Seng Biotech Index.HSBIOup 10.6%","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nL1N44V04C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1583","02162","BK1161","BK1587"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664582856","title":"Keymed Biosciences Signs Licensing Deal for Kangyueda in 18 Markets","url":"https://stock-news.laohu8.com/highlight/detail?id=2664582856","media":"MT Newswires","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664582856?lang=en_us&edition=fundamental","pubTime":"2026-09-03 09:42","pubTimestamp":1788399758,"startTime":"0","endTime":"0","summary":"Keymed Biosciences  has signed a licensing agreement with Singapore-based Aeira to market and sell Kangyueda in 18 markets across Central and Southeast Asia, according to a Wednesday bourse filing.Kangyueda is approved to treat moderate-to-severe atopic dermatitis in adults, chronic rhinosinusitis with nasal polyposis and seasonal allergic rhinitis, the filing said.Under the deal, Keymed will receive an upfront payment, milestone payments upon hitting certain targets and royalties in the high-double-digit percentage range based on regional sales.Aeira will be responsible for regulatory filings and the commercialization of Kangyueda in markets including Singapore, Malaysia, the Philippines, Thailand, Kazakhstan and Uzbekistan, as well as Hong Kong and Macau.Keymed will oversee the production and timely supply of Kangyueda to Aeira.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"b010cf239ffd4765bcd3edd8f767f746","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Keymed Biosciences Signs Licensing Deal for Kangyueda in 18 Markets","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1587","BK1574","BK1583","02162"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1196162450","title":"Final Countdown: Gansu's 16th Provincial Games Kick Off in Just 24 Hours","url":"https://stock-news.laohu8.com/highlight/detail?id=1196162450","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1196162450?lang=en_us&edition=fundamental","pubTime":"2026-09-03 08:41","pubTimestamp":1788396067,"startTime":"0","endTime":"0","summary":"The moment has almost arrived. With just one day remaining until the grand opening of the 16th Gansu Provincial Games, anticipation is building across the region.All preparations are now complete,...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1604","LU2488822045.USD","BK1233","BK1589","06862","BK1591"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664828744","title":"We Might See A Profit From Venus Medtech (Hangzhou) Inc. (HKG:2500) Soon","url":"https://stock-news.laohu8.com/highlight/detail?id=2664828744","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664828744?lang=en_us&edition=fundamental","pubTime":"2026-09-03 06:19","pubTimestamp":1788387559,"startTime":"0","endTime":"0","summary":"We feel now is a pretty good time to analyse Venus Medtech (Hangzhou) Inc.'s ( HKG:2500 ) business as it appears the...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/healthcare/hkg-2500/venus-medtech-hangzhou-shares/news/we-might-see-a-profit-from-venus-medtech-hangzhou-inc-hkg250","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/healthcare/hkg-2500/venus-medtech-hangzhou-shares/news/we-might-see-a-profit-from-venus-medtech-hangzhou-inc-hkg250","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["02500","BK1574","BK1100","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664782876","title":"Asian Growth Companies With High Insider Ownership September 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2664782876","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664782876?lang=en_us&edition=fundamental","pubTime":"2026-09-03 06:08","pubTimestamp":1788386880,"startTime":"0","endTime":"0","summary":"As of September 2026, the Asian markets have shown resilience amid global economic uncertainties, with technology and semiconductor stocks experiencing volatility but ultimately benefiting from strong AI-related demand. In this context, growth companies with high insider ownership can be particularly appealing as they often demonstrate strong alignment between management and shareholder interests, potentially offering stability and confidence in navigating fluctuating market conditions.","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/8042000-choice2-main-header/1585186807378","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/8042000-choice2-main-header/1585186807378"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/software/hkg-1384/deepexi-technology-shares/news/asian-growth-companies-with-high-insider-ownership-september-2","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/software/hkg-1384/deepexi-technology-shares/news/asian-growth-companies-with-high-insider-ownership-september-2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0261950983.USD","LU0588545730.USD","LU1023057109.AUD","LU1808992512.USD","LU0543330483.HKD","LU0828237510.HKD","LU0572944931.SGD","LU1734074674.USD","LU1831875114.USD","LU0449515922.USD","LU0633140727.USD","LU0359201885.HKD","LU0856984785.SGD","IE00BPRC5H50.USD","LU0502904849.HKD","LU1880383440.USD","LU0531971595.HKD","LU0048580855.USD","LU0634319403.HKD","LU0348788117.USD","LU0149721374.USD","LU0132412106.USD","LU2097828474.EUR","LU0828238088.HKD","IE0032431581.USD","LU0455707207.USD","BK1618","LU0541501648.USD","LU0605514214.HKD","KWEB","LU1807302812.USD","LU1048596156.SGD","SG9999002562.SGD","LU0251144936.SGD","SG9999000459.SGD","LU0865486749.SGD","BK1615","LU0320764755.SGD","LU0577902298.EUR","LU0417516738.SGD","LU0499858602.USD","LU0345775950.USD","LU0633140560.USD","LU1675838814.USD","LU1251922891.USD","LU1719994722.HKD","LU0359201612.USD","LU2097828557.USD","LU0417516902.SGD","IE0008368742.USD","LU2097828805.USD","LU2125910500.SGD","LU2476274720.SGD","LU1102505762.USD","LU2242644610.SGD","LU1102505929.USD","LU1813983027.USD","LU0593848301.USD","LU0348805143.USD","LU2097828714.EUR","SG9999002406.SGD","BK6005","LU1064131003.USD","SG9999002828.SGD","BK1583","LU0047713382.USD","LU0345776255.USD","IE00B031HY20.USD","LU0244354667.USD","LU0165289439.USD","LU0611395673.USD","SG9999001903.USD","03690","IE0008369823.USD","LU0326950275.SGD","LU0650527681.SGD","LU2226246903.HKD","LU1794554557.SGD","LU1770034418.SGD","LU0501845795.SGD","LU0594300179.USD","HMTD.SI","LU1960683339.HKD","LU0051755006.USD","LU0823040885.USD","LU0043850808.USD","LU0326948709.USD","LU1152091168.USD","LU0211977185.USD","LU0196878994.USD","BK1142","LU0048597586.USD","LU0828237940.HKD","IE00B29SXG58.USD","LU1303224171.USD","BK1591","LU0821914370.USD","LU0823426308.USD","LU0359202008.SGD","LU0449509016.USD","LU0499858438.USD","LU1224709979.USD","LU0348816934.USD","LU0918141705.HKD","BK1233","LU0140636845.USD","SG9999002414.USD","LU0128522157.USD","LU0269904917.USD","LU0737861699.HKD","LU0823038988.USD","LU0918141887.USD","IE00B3M56506.USD","LU1242518931.SGD","LU0589944569.HKD","LU2045819591.USD","LU0106252389.USD","SG9999001689.USD","LU0084288322.USD","LU0456827905.SGD","LU2087589342.USD","LU1770036033.HKD","LU0117841782.USD","LU2039709279.SGD","LU0456846285.SGD","LU0540923850.HKD","LU1688375341.USD","LU2152927971.USD","01384","IE00BF5LJ272.USD","LU0314109678.HKD","LU0348814723.USD","IE00B5MMRT66.SGD","LU0049853897.USD","LU0577902538.SGD","LU0052750758.USD","LU0588546209.SGD","LU1880383366.USD","LU2399975544.HKD","BK1117","LU0011963245.USD","LU0228659784.USD","LU0370786039.SGD","LU1868838027.USD","LU0588545904.SGD","LU0577902611.USD","LU0287142896.SGD","LU1048588211.SGD","BK1610","LU1868837722.USD","LU0588545490.SGD","LU1961090484.USD","A31.SI","LU1105468828.SGD","LU0541502299.USD","LU0164880469.USD","LU0327786744.USD","LU1328615791.USD","LU0054450605.USD","LU0067412154.USD","LU0431992006.USD","LU0823041008.USD","LU0880133367.SGD","LU1226287529.USD","LU0868486357.SGD","LU2488822045.USD","LU1720050803.USD","LU2778985437.USD","LU0039217434.USD","LU1282648689.USD","LU0672654166.SGD","LU0708995583.HKD","LU1481107354.HKD","BK1575","LU0577902371.SGD","BK6515","IE0034224299.USD","LU1868837565.USD","LU0819121731.USD","LU0594300419.USD","LU1242518857.USD","MPNGY","LU0210526637.USD","LU0143863198.USD","LU2148510915.USD","LU0143863784.USD","LU0979878070.USD","LU1008478684.HKD","LU0823039010.USD","LU1993786604.SGD","LU1188198961.HKD","BK1589","LU0307460666.USD","LU0797268264.HKD","SG9999014674.SGD","LU0823426480.USD","LU0164865239.USD","LU0348825331.USD","LU0054237671.USD","LU0871576103.HKD","LU1152091754.HKD","LU1328277881.USD","LU0072462343.USD","BK1521","LU0181495838.USD","IE00B0JY6N72.USD","LU0214875030.USD","LU2097828631.EUR","IE00B543WZ88.USD","LU0509642566.USD","LU1323998911.USD","LU0873338254.USD","LU1064130708.USD","LU0348735423.USD","LU0577902454.USD","LU0819123356.HKD","LU0029875118.USD","SG9999002463.SGD","LU0164872284.USD","LU0348827113.USD","LU0561508036.HKD","LU0700851271.USD","LU0878005551.USD","METmain","LU2476274308.USD","BK1604","LU0315178854.USD","LU0320764599.SGD","LU2257852520.SGD","SG9999000327.SGD","LU0072913022.USD","LU0231483743.USD","LU0463099449.HKD","LU0683595622.HKD","LU0173614495.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664845176","title":"Brazil Antitrust Body Orders Deeper Delivery Review After Keeta Setback","url":"https://stock-news.laohu8.com/highlight/detail?id=2664845176","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664845176?lang=en_us&edition=fundamental","pubTime":"2026-09-03 02:19","pubTimestamp":1788373146,"startTime":"0","endTime":"0","summary":"Brazil antitrust body orders deeper delivery review after Keeta setbackSAO PAULO, Sept 2 (Reuters)-A tribunal at Brazil's antitrust watchdog Cade on Wednesday rejected an appeal by food delivery compa","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nL6N44U14D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0348814723.USD","LU1282648689.USD","LU0878005551.USD","LU1734074674.USD","LU0823041008.USD","LU0214875030.USD","LU0326948709.USD","BK4535","BK4561","LU1993786604.SGD","LU0577902298.EUR","LU1328277881.USD","BK1142","LU0196878994.USD","LU0047713382.USD","LU0244354667.USD","LU0287142896.SGD","BK1615","LU0164872284.USD","BK1233","LU0605514214.HKD","LU0633140560.USD","LU1048588211.SGD","LU1251922891.USD","LU1152091168.USD","LU1808992512.USD","LU2097828805.USD","LU1868838027.USD","LU0594300179.USD","LU0132412106.USD","LU0029875118.USD","LU0348825331.USD","HMTD.SI","LU0417516738.SGD","LU0327786744.USD","LU0979878070.USD","LU0043850808.USD","LU2087589342.USD","LU0823040885.USD","LU0417516902.SGD","LU0345775950.USD","LU0828237510.HKD","LU1831875114.USD","LU0823426308.USD","LU1770034418.SGD","LU2242644610.SGD","LU0541502299.USD","LU0143863784.USD","LU0359202008.SGD","LU0572944931.SGD","IE0008369823.USD","LU1794554557.SGD","LU0345776255.USD","LU1224709979.USD","SG9999014674.SGD","LU2148510915.USD","LU0261950983.USD","LU0164865239.USD","LU0143863198.USD","LU1675838814.USD","BK4526","BK1589","LU0543330483.HKD","MPNGY","LU0501845795.SGD","LU0828238088.HKD","LU0067412154.USD","LU1770036033.HKD","BK1591","SG9999001903.USD","BK1575","IE00BPRC5H50.USD","SG9999002828.SGD","LU0828237940.HKD","LU0048580855.USD","LU0819121731.USD","LU0737861699.HKD","LU2257852520.SGD","LU0251144936.SGD","LU2488822045.USD","LU0918141705.HKD","LU0589944569.HKD","SG9999002562.SGD","LU0326950275.SGD","LU2097828474.EUR","LU0039217434.USD","IE00BF5LJ272.USD","LU1105468828.SGD","LU1719994722.HKD","LU1880383366.USD","LU0499858602.USD","BK1618","LU0650527681.SGD","LU0856984785.SGD","IE00B543WZ88.USD","IE00B3M56506.USD","LU0577902454.USD","LU0052750758.USD","LU1048596156.SGD","LU0509642566.USD","LU0868486357.SGD","LU2476274720.SGD","LU0072462343.USD","LU0211977185.USD","SG9999002463.SGD","LU0577902611.USD","LU0499858438.USD","LU0054450605.USD","IE0008368742.USD","LU1688375341.USD","BK4505","LU0269904917.USD","IE00B5MMRT66.SGD","LU0165289439.USD","LU0117841782.USD","LU0348788117.USD","LU0611395673.USD","LU0449515922.USD","LU1102505929.USD","LU0051755006.USD","LU2152927971.USD","LU0823039010.USD","LU0588545490.SGD","LU2778985437.USD","LU0871576103.HKD","LU0577902371.SGD","LU0531971595.HKD","LU0823038988.USD","SG9999000459.SGD","LU0634319403.HKD","LU0054237671.USD","LU0463099449.HKD","LU2399975544.HKD","BK4539","LU0011963245.USD","LU0431992006.USD","LU1102505762.USD","LU0231483743.USD","LU0633140727.USD","LU0823426480.USD","LU0541501648.USD","LU0594300419.USD","LU0683595622.HKD","LU1481107354.HKD","LU2097828631.EUR","LU2226246903.HKD","SG9999001689.USD","LU0593848301.USD","LU1807302812.USD","BK4531","LU0348816934.USD","LU1720050803.USD","LU0502904849.HKD","LU0821914370.USD","LU0873338254.USD","LU1023057109.AUD","LU1242518857.USD","LU0561508036.HKD","LU0210526637.USD","LU0072913022.USD","LU0456827905.SGD","LU1960683339.HKD","LU0577902538.SGD","LU2125910500.SGD","DIDI","LU0307460666.USD","LU0181495838.USD","BK1521","LU0540923850.HKD","LU0348827113.USD","LU0359201885.HKD","LU1188198961.HKD","LU1008478684.HKD","LU0128522157.USD","SG9999000327.SGD","LU0048597586.USD","LU0164880469.USD","LU0708995583.HKD","BK4022","IE0034224299.USD","IE00B0JY6N72.USD","LU0348805143.USD","LU1323998911.USD","LU0672654166.SGD","LU0588546209.SGD","BK1583","LU2097828557.USD","LU1813983027.USD","LU1868837565.USD","BK1604","LU0320764755.SGD","LU0819123356.HKD","LU2476274308.USD","LU0140636845.USD","LU1868837722.USD","LU0049853897.USD","LU0918141887.USD","LU0320764599.SGD","LU0106252389.USD","LU1242518931.SGD","METmain","LU0314109678.HKD","LU1880383440.USD","LU1226287529.USD","LU0228659784.USD","LU0700851271.USD","LU1328615791.USD","LU1303224171.USD","LU0456846285.SGD","LU1064131003.USD","LU0588545730.USD","LU2039709279.SGD","BK1610","IE0032431581.USD","LU0348735423.USD","LU1961090484.USD","LU0797268264.HKD","KWEB","LU2097828714.EUR","IE00B29SXG58.USD","LU0370786039.SGD","LU0449509016.USD","LU1152091754.HKD","IE00B031HY20.USD","LU0865486749.SGD","LU0149721374.USD","LU0455707207.USD","LU2045819591.USD","LU1064130708.USD","03690","LU0315178854.USD","LU0359201612.USD","LU0173614495.USD","LU0588545904.SGD","LU0880133367.SGD","LU0084288322.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181297414","title":"HBM Holdings Clarifies Reasons Behind Executive Director's Departure","url":"https://stock-news.laohu8.com/highlight/detail?id=1181297414","media":"Deep News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1181297414?lang=en_us&edition=fundamental","pubTime":"2026-09-02 22:41","pubTimestamp":1788360072,"startTime":"0","endTime":"0","summary":"On September 2nd, HBM Holdings-B issued a supplementary announcement to provide further details on the changes to its directors and authorized representatives that were disclosed on August 27th. The...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02142","BK1574","BK1583","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664817654","title":"Xtep International Holdings (SEHK:1368) Reported Softer Half Year Results, Is The Stock Cheap?","url":"https://stock-news.laohu8.com/highlight/detail?id=2664817654","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664817654?lang=en_us&edition=fundamental","pubTime":"2026-09-02 21:25","pubTimestamp":1788355517,"startTime":"0","endTime":"0","summary":"Why Xtep International Holdings Stock Is In Focus After Its Half Year 2026 Update\nXtep International Holdings (SEHK:1368) moved into the spotlight after its half year 2026 results showed lower sales and net income, alongside an affirmed interim dividend and a refreshed high tech running product lineup.\nDespite the product launch in Shanghai and the half year 2026 earnings announcement on 25 August, Xtep International Holdings’ share price has come under pressure. The stock is down 18.37% on a...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/4131000-choice1-main-header/1585186707756","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/4131000-choice1-main-header/1585186707756"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/consumer-durables/hkg-1368/xtep-international-holdings-shares/news/xtep-international-holdings-sehk1368-reported-softer-half-ye","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/consumer-durables/hkg-1368/xtep-international-holdings-shares/news/xtep-international-holdings-sehk1368-reported-softer-half-ye","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1502","BK1583","BK1168","01368","LU0702159343.USD","LU1166156734.SGD","LU0702159699.USD","BK1512"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664478814","title":"Keymed Biosciences Licenses Stapokibart Marketing, Sales Rights in 18 Southeast and Central Asia Markets to Aeira","url":"https://stock-news.laohu8.com/highlight/detail?id=2664478814","media":"Reuters","labels":["corporation","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664478814?lang=en_us&edition=fundamental","pubTime":"2026-09-02 21:04","pubTimestamp":1788354268,"startTime":"0","endTime":"0","summary":"Keymed Biosciences licenses Stapokibart marketing, sales rights in 18 Southeast and Central Asia markets to AeiraKeymed entered an exclusive licensing deal with Aeira to register and commercialize Sta","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nNDL7LCJLF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02162","BK1583","BK1587","BK1574","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664814417","title":"KeyMed Biosciences - Aeira Responsible for Registration and Commercialization of Stapokibart Injection in 18 Countries and Regions","url":"https://stock-news.laohu8.com/highlight/detail?id=2664814417","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664814417?lang=en_us&edition=fundamental","pubTime":"2026-09-02 21:04","pubTimestamp":1788354266,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nFWN44T1AZ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","BK1587","BK1574","BK1583","02162"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664144128","title":"KeyMed Biosciences - Enters Exclusive Licensing Agreement with Aeira Pte for Stapokibart Injection","url":"https://stock-news.laohu8.com/highlight/detail?id=2664144128","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664144128?lang=en_us&edition=fundamental","pubTime":"2026-09-02 21:04","pubTimestamp":1788354266,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nFWN44T1AZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1583","BK1587","BK1574","02162","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122099918","title":"Simcere Pharma repurchases 1.053 million shares for around HK$12.36 million on September 2","url":"https://stock-news.laohu8.com/highlight/detail?id=1122099918","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1122099918?lang=en_us&edition=fundamental","pubTime":"2026-09-02 20:50","pubTimestamp":1788353410,"startTime":"0","endTime":"0","summary":"On September 2, 2026, Simcere Pharma (02096) spent approximately HK$12.3574 million to buy back 1.053 million shares of the company.This buyback transaction was disclosed in an official announcement from the pharmaceutical firm, reflecting its ongoing capital management strategy.","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","02096","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664148318","title":"Simcere Pharma Files HKEX Next-Day Disclosure Return on Share Repurchase for Cancellation","url":"https://stock-news.laohu8.com/highlight/detail?id=2664148318","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664148318?lang=en_us&edition=fundamental","pubTime":"2026-09-02 20:44","pubTimestamp":1788353098,"startTime":"0","endTime":"0","summary":"Simcere Pharma files HKEX next-day disclosure return on share repurchase for cancellationSimcere repurchased 1,053,000 ordinary shares on Sept. 2 for cancellation, per its HKEX next-day disclosure ret","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nNDLbDL2yy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02096","BK1191","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118027728","title":"REMEGEN Discloses Cumulative Buyback of 41,000 A-Shares by End of August","url":"https://stock-news.laohu8.com/highlight/detail?id=1118027728","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1118027728?lang=en_us&edition=fundamental","pubTime":"2026-09-02 20:04","pubTimestamp":1788350652,"startTime":"0","endTime":"0","summary":"REMEGEN (09995) has released an announcement detailing its share repurchase activities.As of August 31, 2026, the company had repurchased a cumulative total of 41,000 A-shares through the Shanghai...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1064130708.USD","399300","LU2148510915.USD","83188","LU1969619763.USD","BK1161","83130","07233","159982","02827","LU2328871848.SGD","03130","688331","LU1064131003.USD","82846","03188","02846","BK1583","09995","LU2488822045.USD","BK1147","BK1574","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664281963","title":"MicroPort FireShield Coronary Covered Stent Enters China NMPA Innovative Device Review Channel","url":"https://stock-news.laohu8.com/highlight/detail?id=2664281963","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664281963?lang=en_us&edition=fundamental","pubTime":"2026-09-02 19:52","pubTimestamp":1788349964,"startTime":"0","endTime":"0","summary":"MicroPort FireShield coronary covered stent enters China NMPA innovative device review channelMicroPort said its FireShield coronary covered stent system entered China NMPA’s special review pathway fo","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nNDL93Y5wf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00853","BK1100","BK1585","BK1589","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164591890","title":"Executive Director Wang Yuxiao Reduces Stake in Remegen (09995) by 13,500 Shares at Approximately HK$81.54 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=1164591890","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164591890?lang=en_us&edition=fundamental","pubTime":"2026-09-02 19:46","pubTimestamp":1788349577,"startTime":"0","endTime":"0","summary":"According to the latest disclosures from the Hong Kong Stock Exchange, on August 27, executive director Wang Yuxiao sold 13,500 shares of Remegen (09995) at an average price of HK$81.5352 per share,...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","LU1969619763.USD","09995","LU1064130708.USD","LU2148510915.USD","LU2328871848.SGD","BK0239","BK1574","EWH","LU2488822045.USD","LU1064131003.USD","BK1161","688331"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149967319","title":"Shenzhen Regulator Launches 2026 Roadshow Selection for Key Medical Device Innovation Projects","url":"https://stock-news.laohu8.com/highlight/detail?id=1149967319","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1149967319?lang=en_us&edition=fundamental","pubTime":"2026-09-02 19:44","pubTimestamp":1788349448,"startTime":"0","endTime":"0","summary":"To advance high-quality development in the medical device industry and uncover promising local innovations, the Shenzhen Municipal Market Supervision Administration recently organized a roadshow and...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09996","159883","LNGR","BK1583","RSPH","IEIH","BK1574","HART","MEDX","GDOC","MDEV","PTH","BK1100","LGHT","AGNG"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":21,"pageCount":11,"totalSize":407,"code":"91000000","status":"200"}]}}